Deck 16: Ethical Considerations in Marketing

Question 1

Wearables are part of the digital phenotyping that is occurring in today's new healthcare environment.

Answer 1

True

Question 2

HIPAA regulations apply to all wearables and other devices that are involved in the continuous passive assessment of data on individuals' behavior, mood, and cognition.

Answer 2

False

Question 3

The only state that has privacy regulations in place that cover the data generated by personal digital devices that many consumers are unaware of is California.

Answer 3

True

Question 4

When Martin Shrkeli bought the rights to a drug and raised the price from $13.50 to $750, the Department of Justice filed a lawsuit and ultimately imprisoned him for predatory pricing.

Question 5

When people search for a website on plastic surgery, they tend to be particularly concerned about the competency of the physician's skill.

Question 6

By creating a centralized referral center, a health system is ensuring that revenue remains with the health system.

Question 7

More tests are ordered for VIP patients and they are referred to specialists more often.

Question 8

VIP patients have been found to receive above average care compared to the general population.

Question 9

Aging in place service leaders identified three key ethical issues regarding digital technologies for seniors. Which of the following is not one of those dimensions?

A) Privacy
B) Trust
C) Safety
D) Dignity

Question 10

According to HIPAA, which of the following is true regarding the posting of a patient's personal health information (PHI)?

A) It can never be posted or used.
B) It must not be possible to identify the patient, and the patient does not need to be notified.
C) The patient must be informed, and it must not be possible to identify the patient.
D) HIPAA does not address this issue.

Question 11

Which of the following is not a regulation or law that states have passed to prevent large price increases for pharmaceuticals?

A) Jail terms for CEOs or owners of drug companies for exorbitant price increases for critical drugs.
B) Capping co-payments at a defined amount for a particular drug such as insulin.
C) Establishment of a drug affordability board.
D) Requirement to provide a price justification for any price rise over a set amount, such as 20%.

Question 12

According to the AMA, practices can sell health-related products within their practices if they meet which of the following criteria?

A) Provide transparency about the relationship, products have clinical value, risk disclosure
B) Provide transparency about the relationship, offer the product at a discount compared to a local vendor, risk disclosure
C) Risk disclosure, exclusive vendor relationship for a discount, provide delivery for disabled patients
D) The AMA does not endorse selling products within practices.

Question 13

ACOs have created three ways to encourage patients to stay within the healthcare system. Which of the following is not one of these approaches?

A) Financial
B) Structural
C) Nonfinancial
D) Informational

Question 14

Which of the following is a major justification for a VIP being treated differently and not being triaged in an emergency room, but rather taken to an examination room to wait for a clinician?

A) To promote future donations
B) To make room in the emergency room because VIPs are often accompanied by support staff
C) To remove distractions
D) To ensure patient privacy